Name | atogepant |
---|---|
Synonyms |
atogepant
7CRV8RR151 atogepantum (6S)-N-[(3S,5S,6R)-6-Methyl-2-oxo-1-(2,2,2-trifluoroethyl)-5-(2,3,6-trifluorophenyl)-3-piperidinyl]-2'-oxo-1',2',5,7-tetrahydrospiro[cyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridine]-3-carboxamide Spiro[6H-cyclopenta[b]pyridine-6,3'-[3H]pyrrolo[2,3-b]pyridine]-3-carboxamide, 1',2',5,7-tetrahydro-N-[(3S,5S,6R)-6-methyl-2-oxo-1-(2,2,2-trifluoroethyl)-5-(2,3,6-trifluorophenyl)-3-piperidinyl]-2'-oxo-, (6S)- |
Description | A potent, selective and orally available CGRP receptor antagonist for the prevention of migraine. Migraine Phase 3 Clinical |
---|---|
References | References View Related Products by Target CGRP Receptor Migraine |
Density | 1.5±0.1 g/cm3 |
---|---|
Boiling Point | 693.9±55.0 °C at 760 mmHg |
Molecular Formula | C29H23F6N5O3 |
Molecular Weight | 603.515 |
Flash Point | 373.5±31.5 °C |
Exact Mass | 603.170532 |
LogP | 4.37 |
Vapour Pressure | 0.0±2.2 mmHg at 25°C |
Index of Refraction | 1.624 |